|
Elbit Vision Systems Ltd. launched its innovative technology during ITMA exhibition, receiving over $1 M orders (PRNewswire)
October 17, 2011
Kamada: Investment opportunity analysis and buy recommendation (Globes)
September 25, 2011
Kamada Investors Presentation (TASE Filing)
September 1, 2011
Kamada begins manufacturing of snake venom antiserums for Israeli Ministry of Health (Globes)
August 8, 2011
Kamada obtains FDA orphan drug status for diabetes treatment (Globes)
August 3, 2011
Kamada signs rabies vaccine partnership deal in US (MENA.FN)
July 20, 2011
Kamada CEO: “We are heading for another strategic partnership agreement” (Globes)
June 6, 2011
Excellent annual report and projections for Kamada: expect 50% increase in revenue in 2011 (Globes)
March 30, 2011
Sam Cohen and Yaron Menashe turn-around Elbit Vision Systems (TheMarker)
March 23, 2011
Positive interim results for Kamada’s clinical trial using inhaled AAT for treatment of Emphysema (TheMarker)
February 14, 2011
Kamada enters the diabetes market: a new indication for its flagship drug Glassia (TheMarker)
February 9, 2011
Clal Finance raises Kamada’s target share price by 50% following Baxter agreement (TheMarker)
January 23, 2011
|